by The acellular dermal matrices are human skin allografts used for soft tissue reconstruction procedures such as breast reconstruction and abdominal wall reconstruction. Acellular dermal matrices minimize scarring and reduce postoperative wound complication compared to traditional techniques. The acellular dermal matrix provides a scaffold for patient’s own collagen to regenerate, thereby reducing pain and ache. It also reduces morbidity and improves cosmesis.
The global U.S. acellular dermal matrices market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Growing demand for reconstructive surgeries is expected to drive the U.S. acellular dermal matrices market growth over the forecast period. Increasing incidences of breast cancer, burns, and trauma injuries necessitating soft tissue reconstruction is increasing the demand for acellular dermal matrices. According to the American Society of Plastic Surgeons, around 350,000 breast reconstruction procedures are carried out annually in the U.S. Further, growing awareness about cosmetic surgeries is also fueling the number of reconstructive procedures requiring acellular dermal matrices. The ability of acellular dermal matrices to reduce scarring and surgical complications also aids their increasing adoption. However, high costs associated with acellular dermal matrices may hinder market growth.
Segment Analysis
The U.S. Acellular Dermal Matrices market is dominated by the general surgery sub-segment, which holds more than 30% share. Acellular dermal matrices are extensively used in general surgical procedures such as breast reconstruction and hernia repair owing to their ability to provide strength and integrate well with tissues.
PEST Analysis
Political: The market is regulated by the U.S. Food and Drug Administration (FDA) which approves new products and ensures quality standards are followed. Any changes in regulatory policies can impact the market.
Economic: As the U.S. economy grows steady, discretionary healthcare spending is also rising. This augurs well for elective surgical procedures where acellular dermal matrices are used, thereby positively impacting the market.
Social: With increased awareness, more women are opting for breast reconstruction surgeries. Further, rising obesity levels are contributing to hernia cases, propelling demand for acellular dermal matrices.
Technological: Companies are investing in R&D to develop advanced acellular dermal matrices with enhanced integration properties and lower risk of implant complications. 3D-printed matrices offer new opportunities.
Key Takeaways
The Global U.S. Acellular Dermal Matrices Market Growth is expected to witness high over the forecast period of 2023 to 2030. The global U.S. acellular dermal matrices market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.
The South-eastern region dominates the U.S. market owing to presence of many specialized surgical and reconstructive centers. States like Florida and Texas account for sizeable share.
Key players:
Key players operating in the U.S. Acellular Dermal Matrices market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. These companies collectively hold over 60% share. They offer a variety of matrix types for different surgical indications through their extensive distribution networks.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
